By Ben Glickman
Intuitive Machines scheduled a lunar launch in coordination with SpaceX for Jan. 12. The mission includes a lunar lander and is part of a NASA initiative. Shares rise 19%, to $3.18, after-hours.
Coherus BioSciences secured Food and Drug Administration approval for its treatment for nasopharyngeal cancer when combined with chemotherapy. The treatment, called Loqtorzi, is set to become available in the U.S. in the first quarter of 2024. Shares jump 33%, to $3.52, after-hours.
FOXO Technologies said it would enact a 1-for-10 reverse stock split in order to regain compliance with New York Stock Exchange listing requirements. The Minneapolis-based biomarket technology company said the split would become effective Nov. 6. Shares sink 12%, to 8 cents, after-hours.
Write to Ben Glickman at ben.glickman@wsj.com
Read the full article here
